FABIAN ROSEL: Open Payments
NPI 1174925838 · STEUBENVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 49 payments from 11 companies in 2025. Trend: 2023 $506 · 2024 $531 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $253 |
| Axsome Therapeutics, Inc. | 6 | $111 |
| Supernus Pharmaceuticals, Inc. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Lundbeck LLC | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $38 |
Products named: VRAYLAR, Auvelity, ABILIFY MAINTENA, Qelbree, CAPLYTA, Jornay PM, UZEDY, COBENFY.
Industry payments across OH — which companies pay providers there.
